RAB3D and skin carcinoma: The levels of Rab3D in breast, prostate, lung, colon, ovary, liver and skin carcinomas tissues are much higher than that in normal tissues with the IHC analysis, which suggests that Rab3D can be a broad-spectrum diagnostic biomarker for tumor progression in pathological examinations and refers the patients for diagnosis and treatment.